Supernus Pharmaceuticals | Creditori Commerciali



Trade Creditors Cambiamento Data
Abbott USD 11.7B 8.8B 2024-12
ANI Pharmaceuticals USD 45.66M 15.23M 2024-12
Aurora Cannabis CAD 29.52M 20.78M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Canopy Growth CAD 28.92M 3.43M 2024-12
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Indivior 63M 13M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
United Therapeutics 6M 357.9M 2024-12
Xeris Pharmaceuticals USD 2.29M 5.16M 2024-12



Supernus Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.